BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1057 related articles for article (PubMed ID: 19675519)

  • 1. Endocannabinoid system: An overview of its potential in current medical practice.
    Mouslech Z; Valla V
    Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid system in food intake and metabolic regulation.
    Jesudason D; Wittert G
    Curr Opin Lipidol; 2008 Aug; 19(4):344-8. PubMed ID: 18607180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
    Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
    Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system and energy metabolism.
    Bellocchio L; Cervino C; Pasquali R; Pagotto U
    J Neuroendocrinol; 2008 Jun; 20(6):850-7. PubMed ID: 18601709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of the endocannabinoid system in obesity.
    Engeli S
    J Neuroendocrinol; 2008 May; 20 Suppl 1():110-5. PubMed ID: 18426509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system and gut-brain signalling.
    Storr MA; Sharkey KA
    Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
    Dinu IR; Popa S; Bîcu M; Moţa E; Moţa M
    Rom J Intern Med; 2009; 47(1):9-18. PubMed ID: 19886064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
    Saario SM; Laitinen JT
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):287-93. PubMed ID: 17910610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage.
    Trabucco E; Acone G; Marenna A; Pierantoni R; Cacciola G; Chioccarelli T; Mackie K; Fasano S; Colacurci N; Meccariello R; Cobellis G; Cobellis L
    Placenta; 2009 Jun; 30(6):516-22. PubMed ID: 19419760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
    Petrosino S; Di Marzo V
    Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
    Kunos G
    Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas.
    Li C; Jones PM; Persaud SJ
    Pharmacol Ther; 2011 Mar; 129(3):307-20. PubMed ID: 21055418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids affect the reproductive functions in teleosts and amphibians.
    Cottone E; Guastalla A; Mackie K; Franzoni MF
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S41-5. PubMed ID: 18343023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors.
    Woods SC
    Am J Med; 2007 Mar; 120(3 Suppl 1):S19-25. PubMed ID: 17320518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system and the treatment of obesity.
    Pagotto U; Vicennati V; Pasquali R
    Ann Med; 2005; 37(4):270-5. PubMed ID: 16019725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone.
    Grimaldi P; Rossi G; Catanzaro G; Maccarrone M
    Vitam Horm; 2009; 81():231-61. PubMed ID: 19647115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
    Jonsson KO; Holt S; Fowler CJ
    Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction.
    Battista N; Pasquariello N; Di Tommaso M; Maccarrone M
    J Neuroendocrinol; 2008 May; 20 Suppl 1():82-9. PubMed ID: 18426505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.